|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||||||||
| Current Assets | ||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||
| Cash | ||||||||||||||||||
| Short-term investments | ||||||||||||||||||
| Prepaid expenses for forward purchase contract | ||||||||||||||||||
| Other current assets | ||||||||||||||||||
| Total Current Assets | ||||||||||||||||||
| Investments held in Trust Account | ||||||||||||||||||
| Non-current Assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Investment in an equity investee | ||||||||||||||||||
| Right of use assets | ||||||||||||||||||
| Total Non-current Assets | ||||||||||||||||||
| Total Assets | ||||||||||||||||||
| Current Liabilities | ||||||||||||||||||
| Accrued expenses | ||||||||||||||||||
| Franchise tax payable | ||||||||||||||||||
| Income taxes payable | ||||||||||||||||||
| Excise tax payable | ||||||||||||||||||
| Amount due to redeeming shareholders | ||||||||||||||||||
| Loan from related parties | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total loan from related parties | ||||||||||||||||||
| Advance of subscription fees from shareholders | ||||||||||||||||||
| Amount due to related parties | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total amount due to related parties | ||||||||||||||||||
| Other payable and accrued expenses | ||||||||||||||||||
| Lease liabilities, current | ||||||||||||||||||
| Deferred underwriter’s discount | ||||||||||||||||||
| Underwriter fee payable | ||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||
| Deferred underwriters' discount | ||||||||||||||||||
| Deferred underwriters' discount | ||||||||||||||||||
| Non-current Liabilities | ||||||||||||||||||
| Amount due to related parties, non-current | ||||||||||||||||||
| Lease liabilities, non-current | ||||||||||||||||||
| Total Non-current Liabilities | ||||||||||||||||||
| Total Liabilities | ||||||||||||||||||
| Class A common stock subject to possible redemption, 2,604,794 shares and 4,983,493 shares at conversion value of $11.02 and $10.84 per share as of March 31, 2024 and December 31, 2023, respectively | ||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||
| Common stock ($0.0001 par value, 1,000,000,000 shares authorized; 102,597,432 and 70,724,664 shares issued as of June 30, 2026 and December 31, 2025, including 20,000,000 escrowed earnout shares subject to contingent release conditions, respectively; 82,597,432 and 50,724,664 shares outstanding as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||
| Total common stock ($0.0001 par value, 1,000,000,000 shares authorized; 102,597,432 and 70,724,664 shares issued as of June 30, 2026 and December 31, 2025, including 20,000,000 escrowed earnout shares subject to contingent release conditions, respectively; 82,597,432 and 50,724,664 shares outstanding as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||
| Treasury stock | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated loss | ||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||
Loading...
